摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4,5-Dimethyl-benzofuran | 97457-29-9

中文名称
——
中文别名
——
英文名称
4,5-Dimethyl-benzofuran
英文别名
4,5-Dimethylbenzofuran;4,5-dimethyl-1-benzofuran
4,5-Dimethyl-benzofuran化学式
CAS
97457-29-9
化学式
C10H10O
mdl
MFCD18451163
分子量
146.189
InChiKey
BICFOGDDVXBEJA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    11
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.2
  • 拓扑面积:
    13.1
  • 氢给体数:
    0
  • 氢受体数:
    1

反应信息

  • 作为产物:
    描述:
    参考文献:
    名称:
    2-(1-chloro-2-hydroxyethyl)-4,4-dimethylcyclohexa-2,5-dienone: a precursor of 4,5-dimethylbenzo[b]furan from the red alga desmia hornemanni
    摘要:
    DOI:
    10.1016/s0040-4039(00)95091-3
点击查看最新优质反应信息

文献信息

  • SULTAM DERIVATIVES
    申请人:MAEKAWARA Naomi
    公开号:US20090192154A1
    公开(公告)日:2009-07-30
    A sultam derivative of Formula (1) described below having inhibitory action for aggrecanase activity is provided. The sultam derivative of Formula (1) and a salt thereof exhibit strong inhibitory action for aggrecanase activity in a living body of a mammalian animal including human, and is useful, for example, as an active ingredient of a pharmaceutical agent for preventing and/or treating various diseases caused by degradation of aggrecan.
    提供一种以下式(1)描述的磺酰胺衍生物,具有对聚集素酶活性的抑制作用。该式(1)的磺酰胺衍生物及其盐在哺乳动物包括人类的活体内表现出对聚集素酶活性的强抑制作用,并且可用作制药剂的活性成分,用于预防和/或治疗由聚集素降解引起的各种疾病。
  • HETEROCYCLIC COMPOUNDS AND EXPANSION AGENTS FOR HEMATOPOIETIC STEM CELLS
    申请人:Nishino Taito
    公开号:US20120128640A1
    公开(公告)日:2012-05-24
    An expansion agent for hematopoietic stem cells and/or hematopoietic progenitor cells useful for improvement in the efficiency of gene transfer into hematopoietic stem cells for gene therapy useful for treatment of various disorders is provided. An expansion agent for hematopoietic stem cells and/or hematopoietic progenitor cells containing a compound represented by the formula (I) (wherein X, Y, Z, Ar 1 , R 1 , R 2 , R 3 , R 4 , R 5 , R6 and R 7 are as defined in the description), a tautomer, prodrug or pharmaceutically acceptable salt of the compound or a solvate thereof, which can expand hematopoietic stem cells and/or hematopoietic progenitor cells.
    提供一种用于改善基因治疗中将基因转移至造血干细胞以治疗各种疾病的血液干细胞和/或造血祖细胞扩张剂。该扩张剂包含由式(I)表示的化合物(其中X、Y、Z、Ar1、R1、R2、R3、R4、R5、R6和R7如描述中所定义)、该化合物的互变异构体、前药或药学上可接受的盐或其溶剂,能够扩张血液干细胞和/或造血祖细胞。
  • LIQUID CRYSTAL COMPOSITION
    申请人:Sumitomo Chemical Company, Limited
    公开号:US20170335191A1
    公开(公告)日:2017-11-23
    A liquid crystal composition which prevents production of an alignment defect of a liquid crystal compound and also has excellent storage stability during dissolution in a solvent is provided. The liquid crystal composition is suitable for constituting a retardation film capable of favorable circular polarization conversion. The liquid crystal composition includes a polymerizable liquid crystal compound having 3 or more ring structures in the main chain, and aluminum. A content of the aluminum is 1 ppm or more and 170 ppm or less relative to the polymerizable liquid crystal compound.
    提供了一种液晶组合物,可以防止液晶化合物的对准缺陷产生,并且在溶剂中溶解时具有优异的储存稳定性。该液晶组合物适用于构成具有良好圆偏振转换的减速膜。该液晶组合物包括具有3个或更多环结构的可聚合液晶化合物和铝。铝的含量相对于可聚合液晶化合物为1 ppm或更多,170 ppm或更少。
  • METHOD FOR PRODUCING MEGAKARYOCYTES AND/OR PLATELETS FROM PLURIPOTENT STEM CELLS
    申请人:Nissan Chemical Industries, Ltd.
    公开号:EP2765187A1
    公开(公告)日:2014-08-13
    An agent for inducing production of megakaryocytes and/or platelets from pluripotent stem cells which is useful for treatment of disease accompanied by a decrease in platelets is provided. A method for producing megakaryocytes and/or platelets, comprising separating hematopoietic progenitor cells from the septal cells in sac-like structures produced by pluripotent stem cells, and culturing the hematopoietic progenitor cells ex vivo in the presence of a compound represented by the formula (I) (wherein R1 to R7, W, X, Y, Z, Ar1 and n are as defined in the description) to differentiate them into megakaryocytes and/or platelets.
    提供了一种诱导多能干细胞产生巨核细胞和/或血小板的制剂,该制剂可用于治疗伴随血小板减少的疾病。 一种生产巨核细胞和/或血小板的方法,包括在多能干细胞产生的囊状结构中将造血祖细胞从隔细胞中分离出来,并在由式(I)代表的化合物(其中R1至R7、W、X、Y、Z、Ar1和n如描述中所定义)存在下体内外培养造血祖细胞,使其分化成巨核细胞和/或血小板。
  • Liquid crystal composition
    申请人:Sumitomo Chemical Company, Limited
    公开号:US10336938B2
    公开(公告)日:2019-07-02
    A liquid crystal composition containing a polymerizable liquid crystal compound (A) having 5 or more ring structures in its main chain and a polymer (B) of the polymerizable liquid crystal compound (A) having 5 or more ring structures in its main chain, which inhibits occurrence of an orientation defect of a liquid crystal compound and exhibits excellent storage stability when dissolved in a solvent is provided.
    本发明提供了一种液晶组合物,其中含有主链上具有 5 个或更多环状结构的可聚合液晶化合物(A)和主链上具有 5 个或更多环状结构的可聚合液晶化合物(A)的聚合物(B),该组合物能抑制液晶化合物取向缺陷的发生,并在溶解于溶剂中时表现出优异的储存稳定性。
查看更多

同类化合物

()-2-(5-甲基-2-氧代苯并呋喃-3(2)-亚乙基)乙酸乙酯 顺式-1-((2-(5-氯-2-苯并呋喃基)-4-甲基-1,3-二氧戊环-2-基)甲基)-1H-1,2,4-三唑 顺式-1-((2-(5,7-二氯-2-苯并呋喃基)-4-乙基-1,3-二氧戊环-2-基)甲基)-1H-咪唑 顺式-1-((2-(2-苯并呋喃基)-4-乙基-1,3-二氧戊环-2-基)甲基)-1H-1,2,4-三唑 霉酚酸酯杂质B 雷美替胺杂质3 雷美替胺杂质22 雷美替胺杂质 间甲酚紫 间甲基苯基(苯并呋喃-2-基)甲醇 长管假茉莉素C 钠1,4-二[(2-乙基己基)氧基]-1,4-二氧代-2-丁烷磺酸酯-3,3-二(4-羟基苯基)-2-苯并呋喃-1(3H)-酮(1:1:1) 金霉素 酪氨酸,b-羰基- 酞酸酐-d4 酚酞二丁酸酯 酚酞 酚红钠 酚红 邻苯二甲酸酐与马来酸酐,甘氨酰蜡素和二乙二醇的聚合物 邻苯二甲酸酐与己二醇的聚合物 邻苯二甲酸酐与三甘醇异壬醇的聚合物 邻苯二甲酸酐与2-乙基-2-羟甲基-1,3-丙二醇和2,5-呋喃二酮的聚合物 邻苯二甲酸酐与2-乙基-2-羟甲基-1,3-丙二醇、2,5-呋喃二酮和2-乙基己酸苯甲酸酯的聚合物 邻苯二甲酸酐-13C6 邻苯二甲酸酐-4-硼酸频哪醇酯 邻苯二甲酸酐,马来酸,二乙二醇,新戊二醇聚合物 邻甲酚酞二庚酸酯 邻甲酚酞二己酸酯 邻甲酚酞 贝康唑 表灰黄霉素 螺佐呋酮 螺[苯并呋喃-3(2H),4-哌啶] 螺[异苯并呋喃-1(3H),4’-哌啶]-3-酮 螺[异苯并呋喃-1(3H),4'-哌啶]-3-酮盐酸盐 螺[异苯并呋喃-1(3H),3’-吡咯烷]-3-酮 螺[1-苯并呋喃-2,1'-环丙烷]-3-酮 薄荷内酯 萘并[2,3-b]呋喃-8(4H)-酮,4a,5,6,7,8a,9-六氢-,顺- 莫罗卡尼 荨麻叶泽兰酮 荧光胺 苯酞-3-乙酸 苯酚,2-[3-(2-苯并呋喃基)-5,6-二氢-1,2,4-三唑并[3,4-b][1,3,4]噻二唑-6-基]- 苯酐二乙二醇共聚物 苯酐 苯甲酸,2-[(1,3-二羰基丁基)氨基]-,甲基酯 苯甲酸,2,2-二(羟甲基)丙烷-1,3-二醇,异苯并呋喃-1,3-二酮 苯甲酰氯化,3-甲氧基-4-甲基-